Showing results (741-750 of 1,120) with videos related to

Sort By:
Pageof 112
Circulation|March 10, 2016
Trends in Enrollment, Clinical Characteristics, Treatment, and Outcomes According to Age in Non-ST-Segment-Elevation Acute Coronary Syndromes Clinical TrialsKristian Kragholm, Sarah A Goldstein, Qinghong Yang, et al.
Circulation. Cardiovascular Interventions|August 16, 2022
Cardiovascular and Renal Implications of Myocardial Infarction in the ISCHEMIA-CKD TrialBernard R Chaitman, Derek D Cyr, Karen P Alexander, et al.
American Heart Journal|April 30, 2017
Differential occurrence, profile, and impact of first recurrent cardiovascular events after an acute coronary syndromeConnie N Hess, Robert M Clare, Megan L Neely, et al.
Nature Reviews. Cardiology|July 6, 2018
Aspirin-free strategies in cardiovascular disease and cardioembolic stroke preventionDavide Capodanno, Roxana Mehran, Marco Valgimigli, et al.
Blood|October 17, 2014
Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing proceduresDavid Garcia, John H Alexander, Lars Wallentin, et al.
American Heart Journal|July 29, 2014
Prevalence, characteristics, and predictors of early termination of cardiovascular clinical trials due to low recruitment: insights from the ClinicalTrials.gov registrySabrina Bernardez-Pereira, Renato D Lopes, Maria Julia Machline Carrion, et al.
International Journal of Cardiology|June 26, 2018
Definitions of peri-procedural myocardial infarction and the association with one-year mortality: Insights from CHAMPION trialsChristoph B Olivier, Vandana Sundaram, Deepak L Bhatt, et al.
Kidney International|March 3, 2023
The ASCEND-NHQ randomized trial found positive effects of daprodustat on hemoglobin and quality of life in patients with non-dialysis chronic kidney diseaseKirsten L Johansen, Alexander R Cobitz, Ajay K Singh, et al.
JACC. Heart Failure|February 5, 2025
Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy: Design, Rationale, and Baseline Characteristics of ODYSSEY-HCMMilind Y Desai, Steve E Nissen, Theodore Abraham, et al.
JAMA|July 19, 2022
Effect of Omecamtiv Mecarbil on Exercise Capacity in Chronic Heart Failure With Reduced Ejection Fraction: The METEORIC-HF Randomized Clinical TrialGregory D Lewis, Adriaan A Voors, Alain Cohen-Solal, et al.
Pageof 112